Smallpox is an infectious disease caused by the variola virus, which belongs to the genus Orthopoxvirus within the family Poxviridae.[1][3][4] It is an acute contagious illness that affected humans for thousands of years before being declared eradicated.[2][3]
Disease overview
Smallpox
天花
Smallpox is an acute infectious disease caused by the variola virus, a member of the Orthopoxvirus genus, and is historically notable as the only human disease to have been eradicated.[1][2] The last naturally occurring case was diagnosed in Somalia in October 1977, and the World Health Organization certified global eradication in 1980 following an intensive worldwide vaccination and surveillance campaign.[1][2][3] Although it no longer occurs in nature, smallpox remains a concern because of the possible retention of variola virus in laboratories and its recognized potential as a biological threat.[1][4]
Read the full clinical and epidemiological profile6
The initial symptoms of smallpox included high fever, fatigue, severe back pain, and sometimes vomiting or abdominal pain.[1][2][3] Two to three days after fever onset, a characteristic rash developed, beginning on the face and hands and then spreading to the trunk and limbs, while lesions also appeared and ulcerated on the mucous membranes of the nose and mouth.[1][2][3] The skin spots progressed from macules to fluid-filled vesicles with a central depression, then to pustules, and finally formed crusts that dried and fell off, often leaving permanent scars; blindness was a recognized sequela in some survivors.[1][2][3] The overall case fatality rate was about 30%, with higher rates among infants, and a rare hemorrhagic form—variola nigra or "black pox"—was typically fatal.[1][2]
Smallpox was an ancient infectious disease that persisted for millennia, historically manifesting in widespread outbreaks across the globe. Following its introduction to the Americas during the Columbian Exchange, it caused catastrophic mortality among Indigenous populations. During the 18th century, the disease alone was responsible for an estimated 400,000 deaths annually in Europe and accounted for approximately one-third of all blindness cases in the region . Despite being highly contagious, smallpox generally spread more slowly than other viral pathogens because transmission typically required prolonged face-to-face contact and usually occurred only after the onset of the characteristic rash . Epidemiological patterns exhibited seasonal variation, with infection rates peaking during winter and spring in temperate zones, while tropical regions experienced relatively consistent year-round transmission . The demographic profile of infections was heavily influenced by population-level acquired immunity; as vaccine-derived protection waned—typically within three decades—susceptibility increased across broader age groups . The overall case fatality rate hovered around 30%, with elevated mortality observed in infants, and survivors frequently suffered from permanent disfigurement or vision loss . Through a coordinated global vaccination initiative led by the World Health Organization, natural transmission was interrupted, culminating in the last documented indigenous case in Somalia in October 1977 and official certification of global eradication in 1980 . A subsequent isolated incident involving a laboratory accident in Birmingham, England, in 1978 resulted in a minor outbreak and one fatality, but no further natural cases have occurred since [2].
Smallpox was transmitted from person to person primarily through prolonged face-to-face contact with an infected symptomatic individual, via infective droplets.[1][3] Transmission occasionally occurred through contaminated objects such as clothing or bedding.[1][3] The incubation period was 7–17 days, and infected individuals generally became infectious only after the onset of fever and remained contagious until the last scabs fell off.[3]
Smallpox was prevented primarily through vaccination, with the modern vaccine originating from Edward Jenner's 1796 demonstration that inoculation with cowpox material protected against smallpox.[1][3] A worldwide immunization program coordinated by the World Health Organization from 1967 onward, combined with case identification and surveillance, led to the interruption of smallpox transmission.[1][2][3] Vaccination within three days of exposure could prevent or substantially modify the disease, and vaccination four to seven days after exposure could still offer some protection.[1]
- 1Wikipedia contributors. Smallpox - Wikipedia [Internet]. Wikipedia. cited 3 Sept 2026.Available from: https://en.wikipedia.org/wiki/Smallpox
- 2World Health Organization. Smallpox [Internet]. cited 3 Sept 2026.Available from: https://www.who.int/news-room/questions-and-answers/item/smallpox
- 3World Health Organization. Smallpox [Internet]. cited 3 Sept 2026.Available from: https://www.who.int/health-topics/smallpox
- 4Nucera F et al. Poxviridae Pneumonia. Adv Exp Med Biol. 2024. PMID: 38801579. doi: 10.1007/978-3-031-57165-7_12.PubMed: https://pubmed.ncbi.nlm.nih.gov/38801579/
- B03
Coverage
Reporting countries and regions
Trends by reporting country
Monthly patterns over time
Research Radar
Recent related research
APOBEC3-driven attenuation of the 2022 global outbreak monkeypox virus relative to its clade IIb ancestor
Nature Communications
Cross-reactive immunity against orthopoxviruses after monkeypox virus infection or smallpox vaccination
International Journal of Infectious Diseases
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study
The Lancet Infectious Diseases
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study
The Lancet Infectious Diseases
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR. Morbidity and Mortality Weekly Report
Showing 5 of 15 related publications.
Literature links are provided for discovery and do not alter or validate the surveillance series above.
Data access
Page dataset index with source links and update metadata.
Official sourcesAuthority, cadence, notes11
Canada PHAC CNDSS Annual
Canada
Canada is the national jurisdiction; subdivision feeds are registered separately.
Hong Kong, China CHP Notifiable Diseases
Hong Kong, China
Hong Kong, China CHP annual notifiable infectious disease CSVs normalized to national monthly totals
Iceland Directorate of Health Annual Dashboard
Iceland
National annual case notifications by disease. Published values can be revised retrospectively and remain annual period totals.
Iceland Directorate of Health STI Dashboard
Iceland
Monthly STI diagnosis facts from laboratory and registry surveillance; the official dashboard is published on a quarterly schedule.
Iceland Directorate of Health Respiratory Dashboard
Iceland
ISO-week respiratory diagnosis counts. Hospitalizations, samples, and vaccination indicators are separate measures and are not counted as diagnoses.
Iceland Directorate of Health Historical Registry
Iceland
Historical official registry tables for 1997–2021, with annual totals and disease-specific monthly notification facts retained at source grain.
Iceland Directorate of Health Legacy ICD Monthly
Iceland
Historical Saga EHR ICD encounter counts for 1997–2020. This clinical measure is non-comparable with registry notifications and is kept separate.
JP NIID Weekly
Japan
Japan weekly infectious disease surveillance via NIID/JIHS.
Korea KDCA EID
South Korea
Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.
US CDC NNDSS
United States
CDC National Notifiable Diseases Surveillance System provisional data.
US CDC NHSS HIV
United States
CDC NNDSS weekly data plus NHSS annual national HIV diagnoses